Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
MARKETS
SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
INDUSTRY : PHARMACEUTICALS
GLENMARK PHARMACEUTICALS LTD.
Glenmark Pharmaceuticals Ltd.
NSE: GLENMARK | BSE: 532296
Strong Performer, Getting Expensive
Download real time
2222.90
-3.20
(
-0.14
%)
New 52W High in past week
1.2M
NSE+BSE Volume
High vol.+gain this week
NSE
16 Jul, 2025 2:21 PM (IST)
Watchlist
Portfolio
Alert
Share
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
My Notes
Excel Connect
Analyst Buy
Motilal Oswal retains 'Buy' call on Glenmark Pharma, expects a revenue CAGR of 10.6% over FY26-27
See details
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(5)
About
Glenmark Pharmaceuticals Ltd. News, Corporate filings and Earnings/Conference Calls
Keep track of all breaking news and updates on Glenmark Pharmaceuticals Ltd. from all sources in a single place.
All
News
Earnings Calls
Corporate Announcements
Research Reports
Is Glenmark Pharmaceuticals Ltd. worth buying?
569 Votes:
Buy
79.26%
Sell
13.71%
Hold
7.03%
BUY
SELL
HOLD
RESEARCH REPORTS
Buy
SEE REPORTS >
11 Jul 2025
pdf
Glenmark Pharmaceuti..
by Motilal Oswal
| Target:
2430
| Upside:
8.61%
Buy
SEE REPORTS >
11 Jul 2025
pdf
Glenmark Pharmaceuti..
by Deven Choksey
| Target:
1650
Target met
All reports of GLENMARK